KeyBank National Association’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,748
Closed -$235K 1142
2022
Q1
$235K Sell
3,748
-101
-3% -$5.44K ﹤0.01% 987
2021
Q4
$216K Sell
3,849
-503
-12% -$30.7K ﹤0.01% 1035
2021
Q3
$283K Sell
4,352
-14
-0.3% -$955 ﹤0.01% 955
2021
Q2
$277K Buy
4,366
+3
+0.1% +$177 ﹤0.01% 965
2021
Q1
$261K Sell
4,363
-197
-4% -$10.7K ﹤0.01% 964
2020
Q4
$228K Buy
+4,560
New +$214K ﹤0.01% 971

Other funds holding AXNX

KeyBank National Association's AXNX Position: Q2 2022 in Review

KeyBank National Association sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 3,748 shares — an estimated $235K sold.

KeyBank National Association first reported a position in AXNX in Q4 2020 and held it in 6 quarters. The position peaked at $283K in Q3 2021. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

  • KeyBank National Association reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • KeyBank National Association sold 3,748 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $235K.
  • KeyBank National Association first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • KeyBank National Association's Axonics, Inc. Common Stock position peaked at $283K in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on KeyBank National Association's 13F filing for Q2 2022, filed 8 Aug 2022.